This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Andorra Pharmaceuticals, LLC, Sinotherapeutics Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Ziqiang Li: Innovator in Pharmaceutical Composition
Introduction
Ziqiang Li is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the hydration of lyophilized compositions. His innovative methods have the potential to enhance the efficacy of pharmaceutical products.
Latest Patents
Ziqiang Li holds a patent for a "Method for hydrating lyophilized cyclophosphamide composition and product thereof." This patent outlines a hydration method that involves providing an aqueous solution containing cyclophosphamide and an optional pharmaceutically acceptable excipient. The process includes freeze-drying the solution to create a lyophilized composition and subsequently hydrating it with liquid water to obtain the final product. He has 1 patent to his name.
Career Highlights
Throughout his career, Ziqiang Li has worked with prominent companies in the pharmaceutical industry. He has been associated with Sinotherapeutics Inc. and Andorra Pharmaceuticals, LLC, where he has contributed to various innovative projects.
Collaborations
Ziqiang Li has collaborated with several professionals in his field, including Hongzhen Yu and Jiansheng Wan. Their collective expertise has likely enhanced the development of his innovative methods.
Conclusion
Ziqiang Li's work in the hydration of lyophilized pharmaceutical compositions showcases his commitment to advancing medical science. His contributions are valuable to the pharmaceutical industry and have the potential to improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile